Our mission is to improve the quality of preventive medicine, practitioner productivity, patient care and physical performance through nanotechnology-, A.I.- and deep-learning-enabled diagnostics.
2013 Cloth-based Nanosensor technology invented, first patent awarded.
2014 Nanowear founded. Seed round raised.
2016 Nanowear receives first 510(k) clearance from US FDA for SimplECG(TM) utilizing cloth-based nanotechnology, native iOS application and physician web portal.
2017 Nanowear participates in equity-free MedTech Innovator, StartX and PlugNPlay accelerator programs.
2018 Nanowear wins Accenture’s HealthTech Challenge Global Champion at 36th annual JPMorgan Healthcare Conference.
2018 Nanowear one of seven medtech companies selected for Google Launchpad Studio, a six-month artificial intelligence and machine learning scholarship program at Google's campus. Nanowear begins build of both unsupervised and supervised A.I. infrastructure.
2018 Nanowear wins Best in Show and Best Health and Wearable Company at SXSW 2018.
2019 Series A round raised. Nanowear decentralizes supply chain network.
2019 Nanowear's SimpleSENSE achieves first-on-human status, launching clinically in the NanoSENSE clinical trial, a national heart failure study.
2020 NanoCOAT, a COVID-19 clinical trial, launches in New York City hospital systems, expanding nationally. SimpleSENSE 510(k) filed with FDA.
2020 Nanowear receives second 510(k) clearance from US FDA for SimpleSENSE, a multi-parameter remote diagnostic undergarment and machine learning platform.